Nemunaitis J, Cunningham, C ,Bender, J, Ishioka, G, Maples, P, Pappen, B, et al. Phase II trial of a 10 -epitope CTL vaccine , IDM -2101, in metastatic NSCLC patients: Induction of immune responses and clinical efficacy. International Society for Biological Therapy of Cancer 2007, p 891 -2. OSE2101 Protocol OSE2101C301 Confidential Version n°6.0 Page 85 of 101 02 February 2022 54. Nemunaitis J , Nemunaitis M , Senzer N , Snitz P , Bedell C , Kumar P , et al. Phase II trial of Belagenpumatucel -L, a TGF -beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer ( NSCLC) patients. Cancer Gene Ther. 2009;16(8):620 -4. doi: 10.1038/cgt.2009.15. 55.